Atlas Trials

25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial

Clinical trial NCT02447185 · UNKNOWN

Trial details

NCT number
NCT02447185
Sponsor
JUNYAN ZHANG
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy
Start date
2015-06-01
Primary completion
2020-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.